Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.
Koilkonda RD, Yu H, Chou TH, Feuer WJ, Ruggeri M, Porciatti V, Tse D, Hauswirth WW, Chiodo V, Boye SL, Lewin AS, Neuringer M, Renner L, Guy J.
Koilkonda RD, et al. Among authors: guy j.
JAMA Ophthalmol. 2014 Apr 1;132(4):409-20. doi: 10.1001/jamaophthalmol.2013.7630.
JAMA Ophthalmol. 2014.
PMID: 24457989
Free PMC article.
Clinical Trial.